|
Market Closed -
Boerse Muenchen
16:57:44 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 100.00 EUR | +5.54% |
|
+18.73% | +16.54% |
| 08-21 | European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading | MT |
| 08-21 | BioNTech, neoantigens by proxy |  |
| Market Cap | 25.08B 29.28B 23.47B 21.48B 40.32B 2,802B 40.85B 277B 108B 1,407B 110B 108B 4,655B | P/E 2026 * |
-18.1x | P/E 2027 * | -19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 13.72B 16.01B 12.83B 11.75B 22.05B 1,532B 22.34B 152B 59.13B 770B 60.12B 58.81B 2,545B | EV / Sales 2026 * |
7.59x | EV / Sales 2027 * | 8.17x |
| Free-Float |
96.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioNTech SE
| 1 week | +24.07% | ||
| Current month | +27.39% | ||
| 1 month | +23.61% | ||
| 3 months | +27.39% | ||
| 6 months | +6.95% | ||
| Current year | +23.00% |
| 1 week | 78.7 |  | 103.1 |
| 1 month | 75.7 | | 103.1 |
| 3 years | 68.35 | | 124.7 |
| 5 years | 68.35 | | 335.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 2017-12-31 |
Ugur Sahin
CEO | Chief Executive Officer | 60 | 2008-06-01 |
| Director of Finance/CFO | - | 2025-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 55 | 2008-06-01 |
| Director/Board Member | 69 | 2008-06-01 | |
| Director/Board Member | 65 | 2017-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.54% | +18.73% | +4.77% | -7.41% | 27.86B | |
| -3.00% | +0.33% | +77.39% | +109.41% | 73.96B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 64.66B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.32B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 27.86B | |
| +2.74% | +11.55% | +66.56% | +27.34% | 25.97B | |
| +0.47% | +6.22% | +39.36% | -12.38% | 19.98B | |
| +1.82% | -3.11% | +245.72% | +423.83% | 17.84B | |
| +0.94% | +2.38% | +24.83% | +552.12% | 16.24B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.3B | |
| Average | +1.25% | +7.62% | +55.50% | +181.46% | 31.9B | |
| Weighted average by Cap. | +0.68% | +8.75% | +55.09% | +146.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.81B 2.11B 1.69B 1.55B 2.9B 202B 2.94B 19.98B 7.79B 101B 7.92B 7.75B 335B | 1.84B 2.15B 1.72B 1.58B 2.96B 206B 3B 20.38B 7.95B 103B 8.08B 7.91B 342B |
| Net income | -1.35B -1.57B -1.26B -1.15B -2.17B -151B -2.2B -14.91B -5.81B -75.66B -5.91B -5.78B -250B | -1.31B -1.53B -1.23B -1.12B -2.11B -147B -2.14B -14.52B -5.66B -73.68B -5.76B -5.63B -244B |
| Net Debt | -11.37B -13.27B -10.64B -9.74B -18.27B -1,270B -18.52B -126B -49.01B -638B -49.83B -48.75B -2,110B | -10.03B -11.71B -9.39B -8.59B -16.12B -1,120B -16.34B -111B -43.24B -563B -43.97B -43.01B -1,862B |
| Date | Price | Change |
|---|---|---|
| 26-08-21 | €100.00 | +5.54% |
| 26-08-20 | €94.75 | 0.00% |
| 26-08-19 | €94.75 | +18.22% |
| 26-08-18 | €80.15 | +1.39% |
| 26-08-17 | €79.05 | -1.92% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
Select your edition
All financial news and data tailored to specific country editions
